Stock SGRY SURGERY PARTNERS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Surgery Partners, Inc.

Equities

SGRY

US86881A1007

Healthcare Facilities & Services

Real-time Estimate Cboe BZX
Other stock markets
 16:43:45 07/05/2024 BST 		5-day change 1st Jan Change
28.34 USD +10.68% Intraday chart for Surgery Partners, Inc. +13.51% -11.47%
02:43pm Surgery Partners Q1 Adjusted Earnings, Revenue Gain; Boosts 2024 Revenue Outlook MT
02:30pm Transcript : Surgery Partners, Inc., Q1 2024 Earnings Call, May 07, 2024

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 771.7 1,442 4,694 3,370 4,015 3,235 - -
Enterprise Value (EV) 1 3,260 3,981 7,243 5,709 6,594 5,908 5,935 6,142
P/E ratio -6.9 x -9.09 x -47.7 x -47.2 x -355 x 31 x 22.6 x 17.9 x
Yield - - - - - - - -
Capitalization / Revenue 0.42 x 0.78 x 2.11 x 1.33 x 1.46 x 1.08 x 0.99 x 0.91 x
EV / Revenue 1.78 x 2.14 x 3.26 x 2.25 x 2.4 x 1.96 x 1.81 x 1.72 x
EV / EBITDA 12.6 x 15.5 x 21.3 x 15 x 15.1 x 11.9 x 10.6 x 9.83 x
EV / FCF 58.3 x 42.2 x -71.4 x -83.2 x 112 x 58.6 x 25 x -
FCF Yield 1.71% 2.37% -1.4% -1.2% 0.89% 1.71% 3.99% -
Price to Book 2.6 x 12.7 x 3.55 x 1.28 x 2.03 x 1.64 x 1.63 x -
Nbr of stocks (in thousands) 49,296 49,719 87,889 120,948 125,498 126,371 - -
Reference price 2 15.66 29.01 53.41 27.86 31.99 25.60 25.60 25.60
Announcement Date 05/03/20 10/03/21 28/02/22 01/03/23 26/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,831 1,860 2,225 2,539 2,743 3,007 3,273 3,567
EBITDA 1 258.6 256.6 339.6 380.2 438.1 497.4 559 624.7
EBIT 1 171.9 148.6 223.4 247 302.3 493.7 557.9 699.7
Operating Margin 9.39% 7.99% 10.04% 9.73% 11.02% 16.42% 17.05% 19.62%
Earnings before Tax (EBT) 1 54.6 -18.8 81.2 110.3 135 295.8 349.9 -
Net income 1 -109.5 -155.6 -81.2 -54.6 -11.9 105.8 138.8 179.4
Net margin -5.98% -8.37% -3.65% -2.15% -0.43% 3.52% 4.24% 5.03%
EPS 2 -2.270 -3.190 -1.120 -0.5900 -0.0900 0.8259 1.133 1.430
Free Cash Flow 1 55.9 94.4 -101.5 -68.6 58.9 100.8 237 -
FCF margin 3.05% 5.07% -4.56% -2.7% 2.15% 3.35% 7.24% -
FCF Conversion (EBITDA) 21.62% 36.79% - - 13.44% 20.27% 42.39% -
FCF Conversion (Net income) - - - - - 95.31% 170.77% -
Dividend per Share 2 - - - - - - - -
Announcement Date 05/03/20 10/03/21 28/02/22 01/03/23 26/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 559.2 610.2 596.2 615.4 620.6 707.1 666.2 667.6 674.1 735.4 698 728.4 750.8 829.4 771.4
EBITDA 1 76.4 114.4 77.1 86.1 96.2 120.8 90.1 100.2 105.5 142.3 94.73 114.4 126.4 161.8 109.5
EBIT 1 47.1 87.7 46 53.8 61.4 85.8 52.2 71.2 72.2 106.7 86.54 113.2 125.2 168.4 92.65
Operating Margin 8.42% 14.37% 7.72% 8.74% 9.89% 12.13% 7.84% 10.67% 10.71% 14.51% 12.4% 15.54% 16.68% 20.31% 12.01%
Earnings before Tax (EBT) 1 9.4 54.7 44.1 19.6 13.4 33.2 -0.4 49.9 32.8 52.7 38.92 66.91 77 123.5 51.65
Net income 1 -22.9 -0.1 12.2 -18.4 -25 -23.4 -24.9 18.9 -4.9 -1 4.797 18.27 27.49 58.8 14.73
Net margin -4.1% -0.02% 2.05% -2.99% -4.03% -3.31% -3.74% 2.83% -0.73% -0.14% 0.69% 2.51% 3.66% 7.09% 1.91%
EPS 2 -0.2800 -0.001000 0.1400 -0.2100 -0.2800 -0.2300 -0.2000 0.1500 -0.0400 -0.0100 0.0372 0.1346 0.2247 0.3995 0.1300
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 02/11/21 28/02/22 03/05/22 02/08/22 08/11/22 01/03/23 01/05/23 01/08/23 07/11/23 26/02/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,488 2,539 2,549 2,339 2,579 2,673 2,700 2,907
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 9.621 x 9.894 x 7.506 x 6.152 x 5.887 x 5.373 x 4.831 x 4.653 x
Free Cash Flow 1 55.9 94.4 -102 -68.6 58.9 101 237 -
ROE (net income / shareholders' equity) -11.7% -28.8% -0.17% 0.98% 6.36% 4.58% 6.17% 5.57%
ROA (Net income/ Total Assets) - - -0.02% 0.24% 1.87% 1.58% 2.11% -
Assets 1 - - 469,364 -22,989 -636.7 6,687 6,570 -
Book Value Per Share 2 6.020 2.290 15.00 21.70 15.80 15.60 15.80 -
Cash Flow per Share 2 2.680 5.060 1.200 1.730 2.340 3.090 3.480 -
Capex 1 73.6 42.9 57.6 80.6 88.8 115 126 -
Capex / Sales 4.02% 2.31% 2.59% 3.17% 3.24% 3.82% 3.86% -
Announcement Date 05/03/20 10/03/21 28/02/22 01/03/23 26/02/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Surgery Partners, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
25.6 USD
Average target price
42.36 USD
Spread / Average Target
+65.48%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
SURGERY PARTNERS, INC. Stock Surgery Partners, Inc.
-11.47% 3.24B
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-15.68% 17.21B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.54B
IHH HEALTHCARE Stock IHH Healthcare
+4.48% 11.71B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+3.44% 10.43B
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+28.68% 8.51B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-1.92% 7.74B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+20.39% 7.18B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+5.41% 6.55B
GLOBAL HEALTH LIMITED Stock Global Health Limited
+46.01% 4.5B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. SGRY Stock
  4. Financials Surgery Partners, Inc.